Becton Dickinson & Company BD Microtainer PST Tubewith LH (Lithium Heparin) - Amber Part/Catalog Number: 365987 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
BD Microtainer PST Tubewith LH (Lithium Heparin) - Amber Part/Catalog Number: 365987
Brand
Becton Dickinson & Company
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Lot Number/UDI: 819352N (01)30382903659877 (17)190930(10)819352N(30)50 (17)190930(10)819352N(30)200(01)50382903659871 822851N (01)30382903659877 (17)191031(10)822851N(30)50 (17)191031(10)822851N(30)200(01)50382903659871 822852N (01)30382903659877 (17)191031(10)822852N(30)50 (17)191031(10)822852N(30)200(01)50382903659871 822853N (01)30382903659877 (17)191031(10)822853N(30)50 (17)191031(10)822853N(30)200(01)50382903659871 822854N (01)30382903659877 (17)191031(10)822854N(30)50 (17)191031(10)822854N(30)200(01)50382903659871 822855N (01)30382903659877 (17)191031(10)822855N(30)50 (17)191031(10)822855N(30)200(01)50382903659871 822862N (01)30382903659877 (17)191031(10)822862N(30)50 (17)191031(10)822862N(30)200(01)50382903659871 824092N (01)30382903659877 (17)191031(10)824092N(30)50 (17)191031(10)824092N(30)200(01)50382903659871 826768N (01)30382903659877 (17)191130(10)826768N(30)50 (17)191130(10)826768N(30)200(01)50382903659871 827652N (01)30382903659877 (17)191231(10)827652N(30)50 (17)191231(10)827652N(30)200(01)50382903659871 827753N (01)30382903659877 (17)191231(10)827753N(30)50 (17)191231(10)827753N(30)200(01)50382903659871 827754N (01)30382903659877 (17)191231(10)827754N(30)50 (17)191231(10)827754N(30)200(01)50382903659871
Becton Dickinson & Company is recalling BD Microtainer PST Tubewith LH (Lithium Heparin) - Amber Part/Catalog Number: 365987 due to Damaged reservoir may lead to a decreased fill volume causing samples to be insufficient for testing and improper blood-to-additive ratio, potentially. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Damaged reservoir may lead to a decreased fill volume causing samples to be insufficient for testing and improper blood-to-additive ratio, potentially producing erroneous results.
Recommended Action
Per FDA guidance
Becton Dickinson (BD) notified consignees affected by letter via UPS and email dated May 13,2019. Letter describes reason for recall, health risk and action to take: 1. Immediately review your inventory for the specific catalog and lot numbers listed below, 2. Destroy all product subject to the recall following your institution's process for destruction, 3. Share this Urgent Medical Device Recall notification with all users of the product to ensure that they are also aware of this recall, and 4. Complete the attached Customer Response/Certificate of Destruction Forms and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification and process your product replacement. Distributors provide their customer list to BD. BD PAS will notify these customers via mail. BD Contact US Contact Information Customer/Technical Support 888-237-2762 OPT 3, OPT 2; Monday Friday 8:00am - 5:00pm (CT).
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026